Hint mode is switched on Switch off
For swift navigation between sections

Carisma Therapeutics
LEI 549300DGKHONOZQIY116

PDF download

Choose all Reset all
Download Cancel
Organization name
Carisma Therapeutics Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

CARMA Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops novel cellular therapeutics. CARMA Therapeutics serves customers in the State of Pennsylvania.

Awards

News

04/12/2025 Carisma Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Ruleor Standard; Transfer Of Listing, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
14/10/2025 Carisma Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
16/09/2025 Carisma Therapeutics: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Other Events
29/08/2025 Carisma Therapeutics: Unregistered Sales Of Equity Securities, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
05/08/2025 Carisma Therapeutics: Submission Of Matters To A Vote Of Security Holders
All organization news

Documentation

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300DGKHONOZQIY116
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001485003
  • EIN
    26-2025616
Registration is required to get access.